3-Amino-5-Chlorobenzotrifluoride | CAS:69411-05-8

We serve 3-Amino-5-Chlorobenzotrifluoride CAS:69411-05-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Amino-5-Chlorobenzotrifluoride

Chemical Name:  3-Amino-5-Chlorobenzotrifluoride
CAS.NO: 69411-05-8
Synonyms:3-chloro-5-(trifluoromethyl)aniline;
Molecular Formula:C7H5ClF3N
Molecular Weight:195.57000
 
Physical and Chemical Properties:
Density:1.425g/cm3
Melting point:79-82 °C
Boiling point:218.2ºC at 760 mmHg
Flash point:85.8ºC
Index of Refraction:1.5
 
Specification:
Appearance:White Powder
Purity:≥98.0%
 
Packing:25kg/drum,200kg/drum or according to customer request
Storage:Store in a tightly closed container. Store in a cool, dry
Application:  Applicationd as Pharm Intermediates



Contact us for information like 3-Amino-5-Chlorobenzotrifluoride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-chloro-5-(trifluoromethyl)aniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Amino-5-Chlorobenzotrifluoride Use and application,3-chloro-5-(trifluoromethyl)aniline technical grade,usp/ep/jp grade.


Related News: The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.2-Chloro-4-Fluorobenzyl Chloride manufacturer The US National Institutes of Health is working on a preventative vaccine, but it will likely take a few months until the first phase of clinical trials get underway, and more than a year until a vaccine might be available, according to experts.2-Amino-4-bromopyridine supplier CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.3,4-Dimethoxyphenylboronic Acid vendor CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.